August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Diego A. Díaz García: Updates on the treatment of EGFR-mutant NSCLC
Apr 15, 2025, 11:52

Diego A. Díaz García: Updates on the treatment of EGFR-mutant NSCLC

Diego A. Díaz García, Medical Oncologist /CEO/Founder at CánCare – High Specialty in Oncology, shared a post on X:

Updates on the treatment of EGFR-mutant NSCLC.

Third-gen TKIs are standard first-line. Combos with chemo or amivantamab extend PFS (and now OS in Mariposa ph3 trial). Resistance remains a challenge—tailored strategies are key.”

Diego A. Díaz García: Updates on the treatment of EGFR-mutant NSCLC